+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Scandinavia-SmallMidCap

  • ID: 4861659
  • Report
  • September 2019
  • Region: Global
  • 60 pages
  • FinGlobe, Inc
1 of 3

FEATURED COMPANIES

  • 2cureX AB
  • Biotage AB
  • Elos Medtech AB
  • Mentice AB
  • Orphazyme A/S
  • RaySearch Laboratories AB
  • MORE
This trends report provides comprehensive analysis on all licensing deals and negotiations reported for the SmallMidCap healthcare companies of Scandinavia during January 1, 2019 to August 31, 2019, categorized and summarized by various important aspects such as healthcare sub-sectors, medicine groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segment of Scandinavia SmallMidCap sector.

Analytical data coverage:
  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 50+ healthcare licensing news for Scandinavian SmallMidCap healthcare companies (30+)
  • 4 healthcare sub-sectors covered-Pharmaceuticals (19%), Biotech (49%), Medical Devices (24%), Healthcare Services (8%)
  • Listed SmallMidCap companies included (click here to view a list of companies covered)
  • 14 medicine groups studied-Oncology (28%), Radiation Oncology (13%), Neurology (10%)
  • 8+ variables analyzed
Key Features:
  • 8 months’ healthcare licensing transactions of Scandinavia (SmallMidCap) analyzed at one place
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized
The Report is useful to:
  • Scandinavian SmallMidCap companies planning to introduce products in other countries
  • Companies active in R&D and seeking new market base
  • Healthcare company executives of Scandinavia (SmallMidCap) sector negotiating licensing deals
  • Investors analyzing varied kinds of transaction options for licensing deals in Scandinavia (SmallMidCap) sector
Key analysis provided: January-August 2019
  • Total number of licensing deals signed by SmallMidCap companies of Scandinavia
  • Total number of SmallMidCap companies of Scandinavia involved in the licensing deals
  • Most licensing deals signed by which of the Scandinavian countries
  • Most licensing deals signed by which sub-industry within healthcare sector
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 2cureX AB
  • Biotage AB
  • Elos Medtech AB
  • Mentice AB
  • Orphazyme A/S
  • RaySearch Laboratories AB
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions of Scandinavia (SmallMidCap) licensed during last eight months
1.1 Countries with most licensing deals
1.2 Healthcare sub-sectors with most licensing deals
1.3 Medicine groups most active in licensing deals
1.4 Licensing payment arrangements most followed
1.5 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals of Scandinavia (SmallMidCap) by key attributes during last eight months
2.1 For each of the countries
2.2 For each of the healthcare sub-sectors
2.3 For each of the medicine groups
2.4 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed for Scandinavia (SmallMidCap) during last eight months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By medicine group and company name
Appendix 5 List of companies/institutes covered - By terms of payment and company name
Appendix 6 Licensing deals discontinued for Scandinavia (SmallMidCap) during last eight months
Note: Product cover images may vary from those shown
3 of 3
  • 2cureX AB
  • Alligator Bioscience AB
  • Bavarian Nordic AS
  • BioArctic AB
  • BioGaia AB
  • BioInvent International AB
  • Biotage AB
  • Calliditas Therapeutics AB
  • Camurus AB (publ)
  • Cantargia AB
  • Cellink AB
  • C-Rad AB
  • Elos Medtech AB
  • Genovis AB
  • Immunovia AB
  • Infant Bacterial Therapeutics AB
  • IRRAS AB
  • Klaria Pharma Holding AB
  • Mentice AB
  • Moberg Pharma AB
  • Nordic Nanovector ASA
  • Nuevolution AB
  • Orexo AB
  • Orphazyme A/S
  • Ortoma AB
  • Paxman AB
  • PCI Biotech Holding ASA
  • Photocure ASA
  • RaySearch Laboratories AB
  • SenzaGen AB
  • Targovax ASA
  • Umeå University
  • University Hospital Bispebjerg
  • Uppsala University
  • Xvivo Perfusion AB (publ)
  • Zealand Pharma A/S
  • Zelluna Immunotherapy AS
Note: Product cover images may vary from those shown
Adroll
adroll